MR‐proADM as a Prognostic Marker in Patients With ST‐Segment–Elevation Myocardial Infarction—DANAMI‐3 (a Danish Study of Optimal Acute Treatment of Patients With STEMI) Substudy

BACKGROUND: Midregional proadrenomedullin (MR‐proADM) has demonstrated prognostic potential after myocardial infarction (MI). Yet, the prognostic value of MR‐proADM at admission has not been examined in patients with ST‐segment–elevation MI (STEMI). METHODS AND RESULTS: The aim of this substudy, DAN...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Am Heart Assoc
Главные авторы: Falkentoft, Alexander C., Rørth, Rasmus, Iversen, Kasper, Høfsten, Dan E., Kelbæk, Henning, Holmvang, Lene, Frydland, Martin, Schoos, Mikkel M., Helqvist, Steffen, Axelsson, Anna, Clemmensen, Peter, Jørgensen, Erik, Saunamäki, Kari, Tilsted, Hans‐Henrik, Pedersen, Frants, Torp‐Pedersen, Christian, Kofoed, Klaus F., Goetze, Jens P., Engstrøm, Thomas, Køber, Lars
Формат: Artigo
Язык:Inglês
Опубликовано: John Wiley and Sons Inc. 2018
Предметы:
Original Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6015359/
https://ncbi.nlm.nih.gov/pubmed/29776961
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.117.008123
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы